FR2341557B1 - - Google Patents

Info

Publication number
FR2341557B1
FR2341557B1 FR7704568A FR7704568A FR2341557B1 FR 2341557 B1 FR2341557 B1 FR 2341557B1 FR 7704568 A FR7704568 A FR 7704568A FR 7704568 A FR7704568 A FR 7704568A FR 2341557 B1 FR2341557 B1 FR 2341557B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7704568A
Other languages
French (fr)
Other versions
FR2341557A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of FR2341557A1 publication Critical patent/FR2341557A1/fr
Application granted granted Critical
Publication of FR2341557B1 publication Critical patent/FR2341557B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7704568A 1976-02-17 1977-02-17 Nouveaux derives de la 2-phenyl-2-hydroxyethylamine, leur preparation et leur utilisation en tant que medicaments Granted FR2341557A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762606140 DE2606140A1 (de) 1976-02-17 1976-02-17 Neue derivate des 2-phenyl-2-hydroxyaethylamins

Publications (2)

Publication Number Publication Date
FR2341557A1 FR2341557A1 (fr) 1977-09-16
FR2341557B1 true FR2341557B1 (nl) 1980-08-14

Family

ID=5970017

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7704568A Granted FR2341557A1 (fr) 1976-02-17 1977-02-17 Nouveaux derives de la 2-phenyl-2-hydroxyethylamine, leur preparation et leur utilisation en tant que medicaments

Country Status (16)

Country Link
JP (1) JPS52100433A (nl)
AT (1) AT355008B (nl)
AU (1) AU512322B2 (nl)
BE (1) BE851503A (nl)
CH (4) CH634820A5 (nl)
DE (1) DE2606140A1 (nl)
DK (1) DK66177A (nl)
ES (7) ES455942A1 (nl)
FI (1) FI770170A (nl)
FR (1) FR2341557A1 (nl)
GB (1) GB1544883A (nl)
IE (1) IE45186B1 (nl)
LU (1) LU76774A1 (nl)
NL (1) NL7701613A (nl)
NO (1) NO143345C (nl)
SE (1) SE7701724L (nl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0025331B1 (en) * 1979-09-06 1983-03-02 Beecham Group Plc Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them
DE3125870C2 (de) * 1980-07-09 1994-09-15 William John Louis 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
JPWO2008120655A1 (ja) 2007-03-30 2010-07-15 株式会社医薬分子設計研究所 Ｉ型１１βヒドロキシステロイド脱水素酵素阻害活性を有するオキサゾリジノン誘導体

Also Published As

Publication number Publication date
FR2341557A1 (fr) 1977-09-16
NO143345C (no) 1981-01-21
NL7701613A (nl) 1977-08-19
BE851503A (fr) 1977-08-16
FI770170A (nl) 1977-08-18
JPS52100433A (en) 1977-08-23
NO143345B (no) 1980-10-13
NO770509L (no) 1977-08-18
ES464836A1 (es) 1978-08-01
IE45186L (en) 1977-08-17
SE7701724L (sv) 1977-08-18
CH634820A5 (en) 1983-02-28
CH634822A5 (en) 1983-02-28
CH634821A5 (en) 1983-02-28
ES455942A1 (es) 1978-11-01
AT355008B (de) 1980-02-11
LU76774A1 (nl) 1978-04-13
ES464835A1 (es) 1979-09-16
ES464834A1 (es) 1978-09-01
ES464833A1 (es) 1978-09-01
AU2233477A (en) 1978-08-24
GB1544883A (en) 1979-04-25
IE45186B1 (en) 1982-07-14
CH635569A5 (en) 1983-04-15
ES464832A1 (es) 1978-09-01
DE2606140A1 (de) 1977-08-25
AU512322B2 (en) 1980-10-02
DK66177A (da) 1977-08-18
ATA67677A (de) 1979-07-15
ES464837A1 (es) 1978-08-01

Similar Documents

Publication Publication Date Title
FR2375175B1 (nl)
DE2642155C3 (nl)
FR2365916B1 (nl)
DE2634743C2 (nl)
FR2381475B3 (nl)
DE2717303C2 (nl)
FR2338797B1 (nl)
FR2341557B1 (nl)
DE2608011C3 (nl)
JPS5435401Y2 (nl)
JPS5335341U (nl)
JPS5613498Y2 (nl)
JPS52108305U (nl)
JPS5324854U (nl)
JPS5317267U (nl)
JPS52105091U (nl)
JPS52120107U (nl)
JPS5348334U (nl)
JPS52135967U (nl)
JPS5394383U (nl)
CS178349B1 (nl)
JPS5359582U (nl)
JPS5350599U (nl)
DD126663A1 (nl)
DD126104A1 (nl)

Legal Events

Date Code Title Description
ST Notification of lapse